|
AU2006200108A1
|
|
Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media
|
|
WO2006073314A1
|
|
Optical imaging
|
|
NO20052429D0
|
|
The contrast agents
|
|
GB0506057D0
|
|
Devices and method for the penetration of a container stopper
|
|
GB0428020D0
|
|
Stabilisation of radiopharmaceutical precursors
|
|
WO2005058372A1
|
|
Optical imaging contrast agents for imaging lung cancer
|
|
WO2005058371A1
|
|
Optical imaging contrast agents
|
|
WO2005058153A2
|
|
Optical imaging contrast agents comprising a targeting vector linked to a fluorophore
|
|
WO2005058370A1
|
|
Optical imaging contrast agents for imaging lung cancer
|
|
WO2005058846A1
|
|
Process for the porduction of dtpa-bis anhydride
|
|
EP1544634A1
|
|
In vitro method for characterizing the metabolic stability of a hyperpolarized drug candidate
|
|
WO2005053538A2
|
|
Method
|
|
WO2005049095A2
|
|
Contrast agent imaging angiotensin ii receptors
|
|
CN1953772A
|
|
Contrast medium for receptor of angiotensin ii
|
|
WO2005044313A2
|
|
Conjugates of angiotensin ii and an imaging moiety
|
|
WO2005030266A2
|
|
Optical imaging of colorectal cancer
|
|
CN1816519A
|
|
Process for iohexol manufacture
|
|
EP1613973A1
|
|
Compounds generating a dynamic nuclear polarisation process
|
|
EP1438974A2
|
|
pH-sensitive liposomes based on diacyl-glycero-phosphoethanolamine and diacyl-succinyl-glycerol
|
|
WO2004058802A1
|
|
Peptides that bind to the heparin binding domian of vegf and vegfr-2
|
